Companies Cryptocurrencies
Hancock Jaffe Laboratories Inc
Hancock Jaffe Laboratories Inc
Exchange: NasdaqCM
IPO Date: 31/05/2018
CEO: Mr. Robert A. Berman
Medical Devices Healthcare đź”—
  • HJLI
    symbol
  • price
  • market cap
  • changes
If you bought

shares of Hancock Jaffe Laboratories Inc (HJLI) on
You would have made
AMOUNT
today.
Old Price $12 Current Price $12

Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. The company is headquartered in Irvine, California and currently employs 9 full-time employees. The firm is developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD). The firm is in the process of developing bioprosthetic implantable devices for cardiovascular disease. The Company’s Bioprosthetic Heart Valve (BHV), is a bioprosthetic, pig heart valve designed to function like a native heart valve, and designed to provide a patient greater functional performance than available devices. The Company’s product Venous Valve is a bioprosthetic, pig venous valve for patients with lower limb chronic venous insufficiency (CVI), which occurs because of damage to the valves of the veins in the legs after patients develop blood clots in the deep venous system.

Address: 70 Doppler Irvine CALIFORNIA 92618

Stay updated.